As of 2025-09-18, the Fair Value of Celldex Therapeutics Inc (CLDX) is -15.03 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 24.46 USD, the upside of Celldex Therapeutics Inc is -161.44%.
With the market price of 24.46 USD and our fair value calculation, Celldex Therapeutics Inc (CLDX) is not a good investment. Investing in CLDX stocks now will result in a potential loss of 161.44%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -59.78 | -70.51 | -112.33 | -141.43 | -157.86 | -108.38 |
| YoY growth | -17.49% | -17.95% | -59.31% | -25.90% | -11.62% | -26.46% |
| Market Cap (mil) | 1,624.39 |
| P/E | |
| Forward P/E |
| EPS | -3.01 |
| Avg earnings growth rate | -26.46% |
| TTM earnings | -199.61 |